Home
Scholarly Works
Risk of Clinical Outcomes and Baseline Atrial...
Conference

Risk of Clinical Outcomes and Baseline Atrial Fibrillation: Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial

Authors

Oluleye O; Win S; Rector T; Komadja M; Zile M; Mckelvie R; McMurray J; Massie B; Carson P; Anand I

Volume

128

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

November 26, 2013

Name of conference

Scientific Sessions and Resuscitation Science Symposium of the American-Heart-Association

Conference place

Dallas, TX

Conference start date

November 16, 2013

Conference end date

November 17, 2013

Conference proceedings

CIRCULATION

Issue

22

ISSN

0009-7322

Contact the Experts team